Hap Trading, LLC Atea Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$5.33 - $8.18 $129,519 - $198,774	-24,300 Reduced 67.5%	11,700 $12,000
Q1 2022 May 12, 2022	SELL	$5.5 - $9.19 $188,650 - $315,217	-34,300 Reduced 48.79%	36,000 $9,000
Q4 2021 Feb 14, 2022	BUY	$7.67 - $44.59 $423,384 - $2.46 Million	55,200 Added 365.56%	70,300 $16,000
Q3 2021 Nov 10, 2021	BUY	$21.33 - $35.06 $59,723 - $98,168	2,800 Added 22.76%	15,100 $109,000
Q2 2021 Aug 11, 2021	BUY	$19.22 - $59.08 $236,406 - $726,684	12,300 New	12,300 $21,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $275M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.